Request for Covid-19 Impact Assessment of this Report
The United States Neurotrophins market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neurotrophins market, reaching US$ million by the year 2028. As for the Europe Neurotrophins landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Neurotrophins players cover Johnson&Johnson, Lonza Groups, FibroGen, and Scil Proteins GmbH, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurotrophins market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Nerve Growth Factor
Brain-Derived Neurotrophic Factor
Dehydroepiandrosterone Sulfate
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Alzheimer'S Disease
Amyotrophic Lateral Sclerosis
Parkinson'S Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Johnson&Johnson
Lonza Groups
FibroGen
Scil Proteins GmbH
Merck Serono
Scil Proteins GmbH
PeproTech
GE Healthcare
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurotrophins Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Neurotrophins by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Neurotrophins by Country/Region, 2017, 2022 & 2028
2.2 Neurotrophins Segment by Type
2.2.1 Nerve Growth Factor
2.2.2 Brain-Derived Neurotrophic Factor
2.2.3 Dehydroepiandrosterone Sulfate
2.2.4 Other
2.3 Neurotrophins Sales by Type
2.3.1 Global Neurotrophins Sales Market Share by Type (2017-2022)
2.3.2 Global Neurotrophins Revenue and Market Share by Type (2017-2022)
2.3.3 Global Neurotrophins Sale Price by Type (2017-2022)
2.4 Neurotrophins Segment by Application
2.4.1 Alzheimer'S Disease
2.4.2 Amyotrophic Lateral Sclerosis
2.4.3 Parkinson'S Disease
2.4.4 Other
2.5 Neurotrophins Sales by Application
2.5.1 Global Neurotrophins Sale Market Share by Application (2017-2022)
2.5.2 Global Neurotrophins Revenue and Market Share by Application (2017-2022)
2.5.3 Global Neurotrophins Sale Price by Application (2017-2022)
3 Global Neurotrophins by Company
3.1 Global Neurotrophins Breakdown Data by Company
3.1.1 Global Neurotrophins Annual Sales by Company (2020-2022)
3.1.2 Global Neurotrophins Sales Market Share by Company (2020-2022)
3.2 Global Neurotrophins Annual Revenue by Company (2020-2022)
3.2.1 Global Neurotrophins Revenue by Company (2020-2022)
3.2.2 Global Neurotrophins Revenue Market Share by Company (2020-2022)
3.3 Global Neurotrophins Sale Price by Company
3.4 Key Manufacturers Neurotrophins Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurotrophins Product Location Distribution
3.4.2 Players Neurotrophins Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neurotrophins by Geographic Region
4.1 World Historic Neurotrophins Market Size by Geographic Region (2017-2022)
4.1.1 Global Neurotrophins Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Neurotrophins Annual Revenue by Geographic Region
4.2 World Historic Neurotrophins Market Size by Country/Region (2017-2022)
4.2.1 Global Neurotrophins Annual Sales by Country/Region (2017-2022)
4.2.2 Global Neurotrophins Annual Revenue by Country/Region
4.3 Americas Neurotrophins Sales Growth
4.4 APAC Neurotrophins Sales Growth
4.5 Europe Neurotrophins Sales Growth
4.6 Middle East & Africa Neurotrophins Sales Growth
5 Americas
5.1 Americas Neurotrophins Sales by Country
5.1.1 Americas Neurotrophins Sales by Country (2017-2022)
5.1.2 Americas Neurotrophins Revenue by Country (2017-2022)
5.2 Americas Neurotrophins Sales by Type
5.3 Americas Neurotrophins Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurotrophins Sales by Region
6.1.1 APAC Neurotrophins Sales by Region (2017-2022)
6.1.2 APAC Neurotrophins Revenue by Region (2017-2022)
6.2 APAC Neurotrophins Sales by Type
6.3 APAC Neurotrophins Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neurotrophins by Country
7.1.1 Europe Neurotrophins Sales by Country (2017-2022)
7.1.2 Europe Neurotrophins Revenue by Country (2017-2022)
7.2 Europe Neurotrophins Sales by Type
7.3 Europe Neurotrophins Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neurotrophins by Country
8.1.1 Middle East & Africa Neurotrophins Sales by Country (2017-2022)
8.1.2 Middle East & Africa Neurotrophins Revenue by Country (2017-2022)
8.2 Middle East & Africa Neurotrophins Sales by Type
8.3 Middle East & Africa Neurotrophins Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurotrophins
10.3 Manufacturing Process Analysis of Neurotrophins
10.4 Industry Chain Structure of Neurotrophins
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurotrophins Distributors
11.3 Neurotrophins Customer
12 World Forecast Review for Neurotrophins by Geographic Region
12.1 Global Neurotrophins Market Size Forecast by Region
12.1.1 Global Neurotrophins Forecast by Region (2023-2028)
12.1.2 Global Neurotrophins Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neurotrophins Forecast by Type
12.7 Global Neurotrophins Forecast by Application
13 Key Players Analysis
13.1 Johnson&Johnson
13.1.1 Johnson&Johnson Company Information
13.1.2 Johnson&Johnson Neurotrophins Product Offered
13.1.3 Johnson&Johnson Neurotrophins Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Johnson&Johnson Main Business Overview
13.1.5 Johnson&Johnson Latest Developments
13.2 Lonza Groups
13.2.1 Lonza Groups Company Information
13.2.2 Lonza Groups Neurotrophins Product Offered
13.2.3 Lonza Groups Neurotrophins Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Lonza Groups Main Business Overview
13.2.5 Lonza Groups Latest Developments
13.3 FibroGen
13.3.1 FibroGen Company Information
13.3.2 FibroGen Neurotrophins Product Offered
13.3.3 FibroGen Neurotrophins Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 FibroGen Main Business Overview
13.3.5 FibroGen Latest Developments
13.4 Scil Proteins GmbH
13.4.1 Scil Proteins GmbH Company Information
13.4.2 Scil Proteins GmbH Neurotrophins Product Offered
13.4.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Scil Proteins GmbH Main Business Overview
13.4.5 Scil Proteins GmbH Latest Developments
13.5 Merck Serono
13.5.1 Merck Serono Company Information
13.5.2 Merck Serono Neurotrophins Product Offered
13.5.3 Merck Serono Neurotrophins Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Merck Serono Main Business Overview
13.5.5 Merck Serono Latest Developments
13.6 Scil Proteins GmbH
13.6.1 Scil Proteins GmbH Company Information
13.6.2 Scil Proteins GmbH Neurotrophins Product Offered
13.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Scil Proteins GmbH Main Business Overview
13.6.5 Scil Proteins GmbH Latest Developments
13.7 PeproTech
13.7.1 PeproTech Company Information
13.7.2 PeproTech Neurotrophins Product Offered
13.7.3 PeproTech Neurotrophins Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 PeproTech Main Business Overview
13.7.5 PeproTech Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Neurotrophins Product Offered
13.8.3 GE Healthcare Neurotrophins Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
14 Research Findings and Conclusion
Table 1. Neurotrophins Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Neurotrophins Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Nerve Growth Factor
Table 4. Major Players of Brain-Derived Neurotrophic Factor
Table 5. Major Players of Dehydroepiandrosterone Sulfate
Table 6. Major Players of Other
Table 7. Global Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 8. Global Neurotrophins Sales Market Share by Type (2017-2022)
Table 9. Global Neurotrophins Revenue by Type (2017-2022) & ($ million)
Table 10. Global Neurotrophins Revenue Market Share by Type (2017-2022)
Table 11. Global Neurotrophins Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 13. Global Neurotrophins Sales Market Share by Application (2017-2022)
Table 14. Global Neurotrophins Revenue by Application (2017-2022)
Table 15. Global Neurotrophins Revenue Market Share by Application (2017-2022)
Table 16. Global Neurotrophins Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Neurotrophins Sales by Company (2020-2022) & (K Units)
Table 18. Global Neurotrophins Sales Market Share by Company (2020-2022)
Table 19. Global Neurotrophins Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Neurotrophins Revenue Market Share by Company (2020-2022)
Table 21. Global Neurotrophins Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Neurotrophins Producing Area Distribution and Sales Area
Table 23. Players Neurotrophins Products Offered
Table 24. Neurotrophins Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Neurotrophins Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Neurotrophins Sales Market Share Geographic Region (2017-2022)
Table 29. Global Neurotrophins Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Neurotrophins Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Neurotrophins Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Neurotrophins Sales Market Share by Country/Region (2017-2022)
Table 33. Global Neurotrophins Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Neurotrophins Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 36. Americas Neurotrophins Sales Market Share by Country (2017-2022)
Table 37. Americas Neurotrophins Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Neurotrophins Revenue Market Share by Country (2017-2022)
Table 39. Americas Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 40. Americas Neurotrophins Sales Market Share by Type (2017-2022)
Table 41. Americas Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 42. Americas Neurotrophins Sales Market Share by Application (2017-2022)
Table 43. APAC Neurotrophins Sales by Region (2017-2022) & (K Units)
Table 44. APAC Neurotrophins Sales Market Share by Region (2017-2022)
Table 45. APAC Neurotrophins Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Neurotrophins Revenue Market Share by Region (2017-2022)
Table 47. APAC Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 48. APAC Neurotrophins Sales Market Share by Type (2017-2022)
Table 49. APAC Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 50. APAC Neurotrophins Sales Market Share by Application (2017-2022)
Table 51. Europe Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 52. Europe Neurotrophins Sales Market Share by Country (2017-2022)
Table 53. Europe Neurotrophins Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Neurotrophins Revenue Market Share by Country (2017-2022)
Table 55. Europe Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 56. Europe Neurotrophins Sales Market Share by Type (2017-2022)
Table 57. Europe Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 58. Europe Neurotrophins Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Neurotrophins Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Neurotrophins Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Neurotrophins Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Neurotrophins Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Neurotrophins Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Neurotrophins Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Neurotrophins Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Neurotrophins Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Neurotrophins
Table 68. Key Market Challenges & Risks of Neurotrophins
Table 69. Key Industry Trends of Neurotrophins
Table 70. Neurotrophins Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Neurotrophins Distributors List
Table 73. Neurotrophins Customer List
Table 74. Global Neurotrophins Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Neurotrophins Sales Market Forecast by Region
Table 76. Global Neurotrophins Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Neurotrophins Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Neurotrophins Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Neurotrophins Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Neurotrophins Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Neurotrophins Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Neurotrophins Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Neurotrophins Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Neurotrophins Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Neurotrophins Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Neurotrophins Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Neurotrophins Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Neurotrophins Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Neurotrophins Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Neurotrophins Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Neurotrophins Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Neurotrophins Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Neurotrophins Revenue Market Share Forecast by Application (2023-2028)
Table 94. Johnson&Johnson Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 95. Johnson&Johnson Neurotrophins Product Offered
Table 96. Johnson&Johnson Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Johnson&Johnson Main Business
Table 98. Johnson&Johnson Latest Developments
Table 99. Lonza Groups Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 100. Lonza Groups Neurotrophins Product Offered
Table 101. Lonza Groups Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Lonza Groups Main Business
Table 103. Lonza Groups Latest Developments
Table 104. FibroGen Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 105. FibroGen Neurotrophins Product Offered
Table 106. FibroGen Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. FibroGen Main Business
Table 108. FibroGen Latest Developments
Table 109. Scil Proteins GmbH Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 110. Scil Proteins GmbH Neurotrophins Product Offered
Table 111. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Scil Proteins GmbH Main Business
Table 113. Scil Proteins GmbH Latest Developments
Table 114. Merck Serono Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 115. Merck Serono Neurotrophins Product Offered
Table 116. Merck Serono Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Merck Serono Main Business
Table 118. Merck Serono Latest Developments
Table 119. Scil Proteins GmbH Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 120. Scil Proteins GmbH Neurotrophins Product Offered
Table 121. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Scil Proteins GmbH Main Business
Table 123. Scil Proteins GmbH Latest Developments
Table 124. PeproTech Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 125. PeproTech Neurotrophins Product Offered
Table 126. PeproTech Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. PeproTech Main Business
Table 128. PeproTech Latest Developments
Table 129. GE Healthcare Basic Information, Neurotrophins Manufacturing Base, Sales Area and Its Competitors
Table 130. GE Healthcare Neurotrophins Product Offered
Table 131. GE Healthcare Neurotrophins Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. GE Healthcare Main Business
Table 133. GE Healthcare Latest Developments
List of Figures
Figure 1. Picture of Neurotrophins
Figure 2. Neurotrophins Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurotrophins Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Neurotrophins Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Neurotrophins Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Nerve Growth Factor
Figure 10. Product Picture of Brain-Derived Neurotrophic Factor
Figure 11. Product Picture of Dehydroepiandrosterone Sulfate
Figure 12. Product Picture of Other
Figure 13. Global Neurotrophins Sales Market Share by Type in 2021
Figure 14. Global Neurotrophins Revenue Market Share by Type (2017-2022)
Figure 15. Neurotrophins Consumed in Alzheimer'S Disease
Figure 16. Global Neurotrophins Market: Alzheimer'S Disease (2017-2022) & (K Units)
Figure 17. Neurotrophins Consumed in Amyotrophic Lateral Sclerosis
Figure 18. Global Neurotrophins Market: Amyotrophic Lateral Sclerosis (2017-2022) & (K Units)
Figure 19. Neurotrophins Consumed in Parkinson'S Disease
Figure 20. Global Neurotrophins Market: Parkinson'S Disease (2017-2022) & (K Units)
Figure 21. Neurotrophins Consumed in Other
Figure 22. Global Neurotrophins Market: Other (2017-2022) & (K Units)
Figure 23. Global Neurotrophins Sales Market Share by Application (2017-2022)
Figure 24. Global Neurotrophins Revenue Market Share by Application in 2021
Figure 25. Neurotrophins Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Neurotrophins Revenue Market Share by Company in 2021
Figure 27. Global Neurotrophins Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Neurotrophins Revenue Market Share by Geographic Region in 2021
Figure 29. Global Neurotrophins Sales Market Share by Region (2017-2022)
Figure 30. Global Neurotrophins Revenue Market Share by Country/Region in 2021
Figure 31. Americas Neurotrophins Sales 2017-2022 (K Units)
Figure 32. Americas Neurotrophins Revenue 2017-2022 ($ Millions)
Figure 33. APAC Neurotrophins Sales 2017-2022 (K Units)
Figure 34. APAC Neurotrophins Revenue 2017-2022 ($ Millions)
Figure 35. Europe Neurotrophins Sales 2017-2022 (K Units)
Figure 36. Europe Neurotrophins Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Neurotrophins Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Neurotrophins Revenue 2017-2022 ($ Millions)
Figure 39. Americas Neurotrophins Sales Market Share by Country in 2021
Figure 40. Americas Neurotrophins Revenue Market Share by Country in 2021
Figure 41. United States Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Neurotrophins Sales Market Share by Region in 2021
Figure 46. APAC Neurotrophins Revenue Market Share by Regions in 2021
Figure 47. China Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Neurotrophins Sales Market Share by Country in 2021
Figure 54. Europe Neurotrophins Revenue Market Share by Country in 2021
Figure 55. Germany Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Neurotrophins Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Neurotrophins Revenue Market Share by Country in 2021
Figure 62. Egypt Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Neurotrophins Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Neurotrophins in 2021
Figure 68. Manufacturing Process Analysis of Neurotrophins
Figure 69. Industry Chain Structure of Neurotrophins
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...